Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-22
DOI
10.3389/fimmu.2021.790803
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?
- (2021) Piotr Schulz et al. Nutrients
- Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System—Implications for Health and Disease
- (2021) Estefanía Moreno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome
- (2021) Fabiola Forteza et al. Cells
- Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures
- (2020) Vladimir N. Ivanov et al. Scientific Reports
- Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
- (2020) Melanie Kienzl et al. Clinical and Translational Gastroenterology
- Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse
- (2020) Antonelly Cassio Alves de Carvalho et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Guide to Targeting the Endocannabinoid System in Drug Design
- (2020) Adam Stasiulewicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms
- (2020) Dorian Forte et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Roles of G protein-coupled receptors in inflammatory bowel disease
- (2020) Zhen Zeng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
- (2020) Dongchen An et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Immune Endocannabinoid System of the Tumor Microenvironment
- (2020) Melanie Kienzl et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities
- (2020) Samridhi Lal et al. PHARMACOLOGICAL RESEARCH
- Cannabinoid Ligands Targeting TRP Channels
- (2019) Chanté Muller et al. Frontiers in Molecular Neuroscience
- Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer
- (2019) Magdalena Grill et al. Scientific Reports
- Cannabimimetic plants: are they new cannabinoidergic modulators?
- (2019) Amit Kumar et al. PLANTA
- Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment
- (2019) Theodore S. Kapellos et al. FASEB JOURNAL
- Medical cannabis for inflammatory bowel disease
- (2019) Timna Naftali et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- European drug agency approves cannabis-based medicine for severe forms of epilepsy
- (2019) Jacqui Wise BMJ-British Medical Journal
- Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse
- (2019) Tawnya M Hansen et al. INFLAMMATORY BOWEL DISEASES
- The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases
- (2019) Maura Argenziano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Missing Pieces to the Endocannabinoid Puzzle
- (2019) Mauro Maccarrone TRENDS IN MOLECULAR MEDICINE
- Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization
- (2018) Molly Braun et al. BRAIN BEHAVIOR AND IMMUNITY
- Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12
- (2018) Paula Morales et al. DRUG METABOLISM REVIEWS
- A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis
- (2018) Peter M Irving et al. INFLAMMATORY BOWEL DISEASES
- Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease
- (2018) Caterina Strisciuglio et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- P398 Cannabis induces clinical and endoscopic improvement in moderately active ulcerative colitis (UC)
- (2018) T Naftali et al. Journal of Crohns & Colitis
- Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
- (2018) Maria Antonietta De Luca et al. CLINICAL THERAPEUTICS
- Medical Use of Cannabinoids
- (2018) Ana Isabel Fraguas-Sánchez et al. DRUGS
- Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
- (2018) Federica Pellati et al. Biomed Research International
- Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings
- (2017) J. Lötsch et al. EUROPEAN JOURNAL OF PAIN
- Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
- (2017) Gilaad G. Kaplan et al. GASTROENTEROLOGY
- Manipulation of the Endocannabinoid System in Colitis
- (2017) Kristina L. Leinwand et al. INFLAMMATORY BOWEL DISEASES
- An Endocannabinoid Uptake Inhibitor from Black Pepper Exerts Pronounced Anti-Inflammatory Effects in Mice
- (2017) Inés Reynoso-Moreno et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn’s Disease
- (2017) Kristina L Leinwand et al. Journal of Crohns & Colitis
- The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
- (2017) Giulia Donvito et al. NEUROPSYCHOPHARMACOLOGY
- Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling
- (2017) Gernot F. Grabner et al. PHARMACOLOGY & THERAPEUTICS
- Endocannabinoid system acts as a regulator of immune homeostasis in the gut
- (2017) Nandini Acharya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn’s disease and ulcerative colitis
- (2017) Marcin Włodarczyk et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
- (2017) Carina Hasenoehrl et al. Expert Review of Gastroenterology & Hepatology
- The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress
- (2017) Qi-xin Shi et al. Molecular Brain
- Cannabinoid Receptor 1 Participates in Liver Inflammation by Promoting M1 Macrophage Polarization via RhoA/NF-κB p65 and ERK1/2 Pathways, Respectively, in Mouse Liver Fibrogenesis
- (2017) Lei Tian et al. Frontiers in Immunology
- Endocannabinoids in the gastrointestinal tract
- (2016) Yunna Lee et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Genetics and Pathogenesis of Inflammatory Bowel Disease
- (2016) Ta-Chiang Liu et al. Annual Review of Pathology-Mechanisms of Disease
- The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease
- (2016) C. Hasenoehrl et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Wirksamkeit, Verträglichkeit und Sicherheit von Cannabinoiden in der Gastroenterologie
- (2016) M. S. Volz et al. SCHMERZ
- Beyond Cannabis: Plants and the Endocannabinoid System
- (2016) Ethan B. Russo TRENDS IN PHARMACOLOGICAL SCIENCES
- Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine
- (2016) Hui Zhang et al. Acupuncture in Medicine
- An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse
- (2016) Ester Pagano et al. Frontiers in Pharmacology
- Alternative Targets Within the Endocannabinoid System for Future Treatment of Gastrointestinal Diseases
- (2016) Rudolf Schicho et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Fasting stimulates 2-AG biosynthesis in the small intestine: role of cholinergic pathways
- (2015) Nicholas V. DiPatrizio et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis
- (2015) Mireille Alhouayek et al. FASEB JOURNAL
- Role of G Protein-coupled Orphan Receptors in Intestinal Inflammation
- (2015) Andrzej Wasilewski et al. INFLAMMATORY BOWEL DISEASES
- New insights on the role of the endocannabinoid system in the regulation of energy balance
- (2015) B Gatta-Cherifi et al. INTERNATIONAL JOURNAL OF OBESITY
- Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors
- (2015) Rosaria I. Staiano et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review
- (2015) Francesca Algieri et al. MEDIATORS OF INFLAMMATION
- The GPR55 antagonist CID16020046 protects against intestinal inflammation
- (2015) A. Stančić et al. NEUROGASTROENTEROLOGY AND MOTILITY
- The Endocannabinoid System and its Modulation by Phytocannabinoids
- (2015) Vincenzo Di Marzo et al. Neurotherapeutics
- Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent
- (2014) Francesca Borrelli et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohnʼs Disease
- (2014) Martin Storr et al. INFLAMMATORY BOWEL DISEASES
- Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)
- (2014) M. Sałaga et al. Journal of Crohns & Colitis
- Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors
- (2014) Jakub Fichna et al. PLoS One
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
- (2013) Francesca Borrelli et al. BIOCHEMICAL PHARMACOLOGY
- Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study
- (2013) Timna Naftali et al. Clinical Gastroenterology and Hepatology
- A potential role for GPR55 in the regulation of energy homeostasis
- (2013) Anna C. Simcocks et al. DRUG DISCOVERY TODAY
- Mechanisms and clinical uses of capsaicin
- (2013) Surinder Kumar Sharma et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system
- (2013) Keith A. Sharkey et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation
- (2013) Giuseppe Esposito et al. GUT
- Diverse novel functions of neutrophils in immunity, inflammation, and beyond
- (2013) Attila Mócsai JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis
- (2013) Yu Y Li et al. LABORATORY INVESTIGATION
- Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system
- (2013) Israel Matos et al. MOLECULAR IMMUNOLOGY
- Patients with IBD find symptom relief in the Cannabis field
- (2013) Rudolf Schicho et al. Nature Reviews Gastroenterology & Hepatology
- The Cannabinoid Receptor Type 2 as Mediator of Mesenchymal Stromal Cell Immunosuppressive Properties
- (2013) Francesca Rossi et al. PLoS One
- Prostaglandin ethanolamides attenuate damage in a human explant colitis model
- (2013) Lauren L. Nicotra et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors
- (2012) A Chicca et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention
- (2012) Francesca Rossi et al. PHARMACOLOGICAL RESEARCH
- The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
- (2012) Mireille Alhouayek et al. TRENDS IN MOLECULAR MEDICINE
- Cannabis use amongst patients with inflammatory bowel disease
- (2011) Simon Lal et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
- (2011) Mireille Alhouayek et al. FASEB JOURNAL
- The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease
- (2011) A Di Sabatino et al. Mucosal Immunology
- A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents
- (2011) X.-H. Lin et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Activation of cannabinoid receptors by the pentacyclic triterpene α,β-amyrin inhibits inflammatory and neuropathic persistent pain in mice
- (2011) Kathryn A.B. Simão da Silva et al. PAIN
- Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception
- (2011) Aldric Hama et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Activation of GPR4 by Acidosis Increases Endothelial Cell Adhesion through the cAMP/Epac Pathway
- (2011) Aishe Chen et al. PLoS One
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?
- (2011) P. Pacher et al. PROGRESS IN LIPID RESEARCH
- Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10−/− mice by attenuating the activation of T cells and promoting their apoptosis
- (2011) Udai P. Singh et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Endocannabinoid biosynthesis and inactivation, from simple to complex
- (2010) Giulio G. Muccioli DRUG DISCOVERY TODAY
- The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment
- (2010) Rudolf Schicho et al. INFLAMMATORY BOWEL DISEASES
- Cannabinoid-induced reduction in antral pacemaker frequency: a telemetric study in the ferret
- (2010) N. Percie Du Sert et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors
- (2010) Maria Teresa Cencioni et al. PLoS One
- CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages
- (2009) K. H. Han et al. CARDIOVASCULAR RESEARCH
- Endocannabinoid chemical biology: a tool for the development of novel therapies
- (2009) Stefania Petrosino et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
- (2009) Sadiye Amcaoglu Rieder et al. IMMUNOBIOLOGY
- Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis
- (2009) Martin A. Storr et al. INFLAMMATORY BOWEL DISEASES
- Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue
- (2009) Lucia Marquéz et al. PLoS One
- Receptors for acylethanolamides—GPR55 and GPR119
- (2009) Grzegorz Godlewski et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- 2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55
- (2008) S. Oka et al. JOURNAL OF BIOCHEMISTRY
- Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells
- (2008) V. L. Hegde et al. MOLECULAR PHARMACOLOGY
- The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain
- (2008) Penny C. Staton et al. PAIN
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
- (2008) J. E. Lauckner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GPR55: a new member of the cannabinoid receptor clan?
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started